Key facts
- This page summarizes Vladimir P. Torchilin's Form 4 filing for Immix Biopharma, Inc. (IMMX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 20 Dec 2021, 15:15.
Vladimir P. Torchilin - 20 Dec 2021 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)
- Reporting relationship
- Scientific Co-Founder
- Issuer ticker
- IMMX
- Reported as of
- 20 Dec 2021
- Net transaction value
- +$24,834
- SEC form
- 4
- Accepted by SEC
- 20 Dec 2021, 15:15:22 UTC
- Prior SEC filing
- 15 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ilya Rachman as Attorney-In-Fact for Vladimir Torchilin
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Vladimir P. Torchilin filed Form 4 for Immix Biopharma, Inc. (IMMX) on 20 Dec 2021.
Change
- Previous filing in this sequence was filed on 15 Dec 2021.
- Current net transaction value: +$24,834.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMMX
transaction
Common Stock
Purchase
- Transaction value
- $9,834
- Shares
- +2,200
- Change %
- +0.24%
- Price
- $4.47
- Shares after
- 902,200
- Date
- 17 Dec 2021
- Ownership
- Direct
IMMX
transaction
Common Stock
Purchase
- Transaction value
- $15,000
- Shares
- +3,000
- Change %
- +0.33%
- Price
- $5.00
- Shares after
- 905,200
- Date
- 20 Dec 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.